ATE490981T1 - Criptospezifische antikörper - Google Patents

Criptospezifische antikörper

Info

Publication number: ATE490981T1
Authority: AT; Austria
Prior art keywords: cripto; antibodies; inhibit; bind; specific antibodies
Prior art date: 2002-03-22

Application number

AT02807155T

Other languages

English (en)

Inventor

Michele Sanicola-Nadel

Huet Heather Adkins

Steven Donald Miklasz

Paul Rayhorn

Susan Gail Schiffer

Kevin Williams

Original Assignee

Biogen Idec Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-03-22

Filing date

2002-10-01

Publication date

2010-12-15

2002-04-17 Priority claimed from PCT/US2002/011950 external-priority patent/WO2002088170A2/en

2002-10-01 Application filed by Biogen Idec Inc filed Critical Biogen Idec Inc

2002-10-01 Priority claimed from PCT/US2002/031462 external-priority patent/WO2003083041A2/en

2010-12-15 Application granted granted Critical

2010-12-15 Publication of ATE490981T1 publication Critical patent/ATE490981T1/de

Links

101100369076 Mus musculus Tdgf1 gene Proteins 0.000 abstract 9
230000000694 effects Effects 0.000 abstract 2
230000004614 tumor growth Effects 0.000 abstract 2
102100034134 Activin receptor type-1B Human genes 0.000 abstract 1
101000799189 Homo sapiens Activin receptor type-1B Proteins 0.000 abstract 1
108010023079 activin B Proteins 0.000 abstract 1
239000012634 fragment Substances 0.000 abstract 1
230000003993 interaction Effects 0.000 abstract 1
230000001225 therapeutic effect Effects 0.000 abstract 1

Landscapes

Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Investigating Or Analysing Biological Materials (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AT02807155T 2002-03-22 2002-10-01 Criptospezifische antikörper ATE490981T1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US36700202P	2002-03-22	2002-03-22
PCT/US2002/011950 WO2002088170A2 (en)	2001-04-26	2002-04-17	Cripto blocking antibodies and uses thereof
PCT/US2002/031462 WO2003083041A2 (en)	2002-03-22	2002-10-01	Cripto-specific antibodies

Publications (1)

Publication Number	Publication Date
ATE490981T1 true ATE490981T1 (de)	2010-12-15

Family

ID=34061765

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT02807155T ATE490981T1 (de)	2002-03-22	2002-10-01	Criptospezifische antikörper

Country Status (8)

Country	Link
JP (1)	JP2009161539A (de)
AT (1)	ATE490981T1 (de)
CA (1)	CA2480119C (de)
CY (1)	CY1111320T1 (de)
DE (1)	DE60238559D1 (de)
DK (1)	DK1494693T3 (de)
ES (1)	ES2355363T3 (de)
PT (1)	PT1494693E (de)

2002
- 2002-10-01 AT AT02807155T patent/ATE490981T1/de active
- 2002-10-01 DK DK02807155.3T patent/DK1494693T3/da active
- 2002-10-01 PT PT02807155T patent/PT1494693E/pt unknown
- 2002-10-01 ES ES02807155T patent/ES2355363T3/es not_active Expired - Lifetime
- 2002-10-01 DE DE60238559T patent/DE60238559D1/de not_active Expired - Lifetime
- 2002-10-01 CA CA2480119A patent/CA2480119C/en not_active Expired - Fee Related
2009
- 2009-01-30 JP JP2009020949A patent/JP2009161539A/ja active Pending
2011
- 2011-03-08 CY CY20111100269T patent/CY1111320T1/el unknown

Also Published As

Publication number	Publication date
PT1494693E (pt)	2011-02-23
ES2355363T3 (es)	2011-03-25
DE60238559D1 (de)	2011-01-20
HK1072381A1 (en)	2005-08-26
CA2480119A1 (en)	2003-10-09
DK1494693T3 (da)	2011-01-17
CY1111320T1 (el)	2015-08-05
CA2480119C (en)	2014-04-08
JP2009161539A (ja)	2009-07-23

Similar Documents

Publication	Publication Date	Title
WO2003083041A3 (en)	2003-12-04	Cripto-specific antibodies
MY150237A (en)	2013-12-31	Cripto blocking antibodies and uses thereof
BR0011838A (pt)	2002-03-05	Elementos misturadores estáticos empilhados
CY1111622T1 (el)	2015-10-07	Ανθρωποποιημενοι ανταγωνιστες anti-cmet
SI1615952T1 (sl)	2012-03-30	Metoda zdravljenja vnetnih bolezni z uporabo specifičnih veznih sredstev humanega angiopoetin
NO20041917D0 (no)	2004-05-10	Spesifikke midler som binder humant angiopoietin-2
TNSN05300A1 (en)	2007-07-10	Treatment with anti-vegf antibodies
AU2003205077A1 (en)	2003-07-30	Imaging agents and methods of imaging naaladase of psma
EP1844077A4 (de)	2010-03-17	Dr5-antikörper und deren verwendung
MY136095A (en)	2008-08-29	Use of human anti-ctla-4 antibodies for treatment of cancer
TW200738270A (en)	2007-10-16	Method of treating depression using a TNFα antibody
IL163902A0 (en)	2005-12-18	Antibodies against cancer antigen tmeff2 and uses thereof
EA200602047A1 (ru)	2007-06-29	Сульфонилэтилфосфородиамидаты, предназначенные для применения при лечении рака
ATE490981T1 (de)	2010-12-15	Criptospezifische antikörper
ATE528392T1 (de)	2011-10-15	Neues protein und dessen dns
DE50210279D1 (de)	2007-07-19	Screeningverfahren mit bnpi und dnpi
TW200635950A (en)	2006-10-16	Specific binding agents of human angiopoietin-2
WO2005105143A3 (en)	2006-04-27	Vaccines and antibodies against ltk for therapy of cancers.

Legal Events

Date

Code

Title

Description

2011-09-15

UEP

Publication of translation of european patent specification

Ref document number: 1494693

Country of ref document: EP